期刊
CIRCULATION
卷 139, 期 22, 页码 2591-2593出版社
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1161/CIRCULATIONAHA.119.040057
关键词
canagliflozin; heart failure; randomized trial; SGLT2 inhibitor; type 2 diabetes mellitus
资金
- Janssen Research & Development, LLC